Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Pressure Biosciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
PBIO
Over the counter
8731
http://www.pressurebiosciences.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Pressure Biosciences Inc
Richard T. Schumacher, CEO of Pressure BioSciences, Inc., Discusses Strong Finish to 2017 and Operational Developments for 2018 on Uptick Newswire’s “Stock Day” Podcast with Everett Jolly
- Apr 10th, 2018 9:38 am
Pressure BioSciences, Inc. Reports Fourth Quarter and Fiscal Year 2017 Financial Results and Provides Business Update
- Apr 3rd, 2018 9:49 am
Pressure BioSciences, Inc. to Discuss Fourth Quarter and FY2017 Financial Results and Provide Business Update
- Mar 29th, 2018 6:16 am
Richard T. Schumacher, CEO of Pressure BioSciences, Inc., Returns to Uptick Newswire's "Stock Day" Podcast with Everett Jolly to Review Significant Achievements in 2017 and Discuss Exciting Developments Expected in 2018
- Mar 13th, 2018 6:08 am
Pressure BioSciences, Inc. and ISS, Inc. Announce Two-Year Worldwide Co-Marketing and Distribution Agreement
- Feb 14th, 2018 6:44 am
WallStreet Research(TM) Announces Availability of Updated Corporate Profile Coverage on Pressure BioSciences, Inc. (OTCQB: PBIO)
- Feb 9th, 2018 5:00 am
Pressure BioSciences, Inc. CEO, Ric Schumacher, Rejoins “Stock Day”, Very Optimistic About His Company’s Growth and Success in 2018 and Beyond
- Jan 29th, 2018 9:09 am
Pressure BioSciences, Inc., a Leader in the Sale of Pressure-Based Solutions for the Worldwide Life Sciences Market, to Host Webinar Update for Investors
- Jan 29th, 2018 9:08 am
PBIO: Enters Biopharmaceutical Quality Control Market
- Dec 21st, 2017 11:00 am
Pressure BioSciences Enters Biopharmaceutical Quality Control Market with Significant Software Upgrade for Its Flagship Barocycler 2320EXTREME
- Dec 20th, 2017 7:35 am
Pressure BioSciences, Inc. to Host Business Update on Wednesday, December 20th at 4:30 pm EST
- Dec 18th, 2017 7:29 am
Pressure BioSciences Announces Acquisition of All Assets of BaroFold, Inc.
- Dec 13th, 2017 7:15 am
Pressure BioSciences, Inc. :PBIO-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017
- Nov 29th, 2017 5:32 am
PBIO: Revenue Expected to Continue to Grow
- Nov 15th, 2017 12:00 pm
Pressure BioSciences, Inc. Reports Third Quarter 2017 Financial Results and Provides Business Update
- Nov 14th, 2017 9:07 am
Pressure BioSciences, Inc. to Discuss Third Quarter 2017 Financial Results and Provide Business Update
- Nov 13th, 2017 8:06 am
Pressure BioSciences Initiates Aggressive Marketing and Sales Strategy Expected to Drive Significant Expansion into China
- Nov 1st, 2017 7:30 am
NetworkNewsWire Releases Exclusive Audio Interview with Pressure BioSciences Inc. (PBIO)
- Oct 26th, 2017 7:00 am
Pressure BioSciences, Inc. Discusses Market Opportunity, Differentiating Factors and New Patents in New SNNLive Video Interview with StockNewsNow.com
- Oct 24th, 2017 6:00 am
Scroll